Trade volumes are expected to decline in 2025 and 2026, as elevated trade policy uncertainty dampens investment and disrupts ...

Growth divergences persist and could widen, while policy shifts may reignite inflation pressures in some countries ...

The threat of tariffs on rooftop solar components will lead to price increases for consumers, but likely won't slow overall ...

Global growth is expected to increase slightly this year while remaining stuck below its pre-pandemic average, the IMF said ...

Amid potential threats to CT's energy goals — some directly from Trump — how can CT move ahead with its ambitious energy ...

Bond yields dipped for a third day on Friday, bringing some relief to investors after they watched the 10-year approach 5% in ...

The world’s second-largest cryptocurrency, ethereum, and XRP, also posted gains this week. Ethereum is currently trading at ...

Investors are appraising Trump policies' likely impact on stocks on the last trading day before the inauguration.

Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...

The list of 15 drugs ( up from 10 in 2023) includes four oncology drugs, three drugs targeting diabetes, two focused on COPD, ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health ...